Tumor-specific DNA in plasma of breast cancer patients

Anti-Cancer Drugs

Volumn 13, Issue 4, 2002, Pages 353-357

  Shao, Zhi Ming ^a   Nguyen, Mai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast carcinoma; p53 mutation; Plasma DNA; Tumor marker

Indexed keywords

DNA FRAGMENT; PROTEIN P53; RAS PROTEIN;

ADULT; AGED; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER PATIENT; CARCINOMA IN SITU; CELL DEATH; CONTROLLED STUDY; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY;

ADULT; AGED; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTATION; PROMOTER REGIONS (GENETICS); TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036242578     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200204000-00003     Document Type: Short Survey

References (38)

1. Genetic model for colorectal tumorigenesis
2. TP53 gene mutations in plasma DNA of cancer patients
3. Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlation
4. Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 mutations using cDNA sequencing in human breast tumor
5. Circulating DNA in plasma or serum
6. Radioimmunoassay for nanogram quantities of DNA
7. Isolation and characterization of DNA from plasma of cancer patients
8. Neoplastic characteristics of the DNA found in the plasma of cancer patients
9. Microsatellite alterations in plasma DNA of small cell lung cancer patients
10. Microsatellite alterations in serum DNA of head and neck cancer patients
11. K-ras mutations are found in DNA extraction from the plasma of patients with colorectal cancer
12. Free DNA in the serum of cancer patients and the effect of therapy
13. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
14. Loss of c-H-ras-a allele and aggressive human primary breast carcinoma
15. Activation of ras oncogenes preceding the onset of neoplasia
16. An overexpression N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis
17. P53 mutations in BRCA-1 associated familial breast cancer
18. p53 mutations in human cancer
19. p53 mutation in plasma DNA and its prognostic value in breast cancer patients
20. K-ras mutations in DNA extracted from plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
21. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
22. TP53 gene mutations in plasma DNA of cancer patients
23. Microsatellite abnormalities in plasma of patients with breast carcinoma: Concordance with the primary tumour
24. Laser-fluorescence microsatellite analysis and new results in microsatellite analysis of plasma/serum DNA of cancer patients
25. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer
26. Microsatellite alterations plasma DNA of primary breast cancer patients
27. Microsatellite instability in breast cancer
28. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer
29. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer
30. Microsatellite abnormalities in plasma of patients with breast carcinoma: Concordance with the primary tumour
31. Microsatellite alterations plasma DNA of primary breast cancer patients
32. Mutations in normal breast tissue and breast tumours
33. Genomic instability and breast cancer
34. A new regulatory motif in cell-cycle control using specific inhibitions of cyclin D/CDK4
35. Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
36. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
37. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer
38. Telomerase RNA as a detection marker in the serum of breast cancer patients